Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers study potential cancer suppression in cetaceans
Researchers sequenced and assembled the genome of a humpback whale.
Findings could help find new treatments for human cancers 

A study of potential cancer suppression in cetaceans could help researchers discover new targets for preventing cancer in humans.

The research, published in Molecular Biology and Evolution, pulled apart the genome of a humpback whale, along with nine other cetaceans, to reveal how their cancer defences are so effective.

Study leader Professor Marc Tollis from Northern Arizona University said the study found ‘nature has beaten cancer in countless ways across the tree of life’.

He added that scientists can use the information to help find new treatments for human cancers. For example, using the whale version of a protein that can prevent cell growth to develop drugs that shrink tumours in humans.

“Our goal is not only to get nature to inform us about better cancer therapies but to give the public a new perspective of cancer,” Tollis said. “The fact that whales and elephants evolved to beat cancer, and that dinosaurs suffered from it as well, suggests that cancer has been a selective pressure across many millions of years of evolution, and it has always been with us.

“Our hope is that this may change people’s relationship with the disease, which can be painful and personal. It also helps provide even better appreciation for biodiversity. In our current sixth mass extinction, we need all the reasons for conservation that we can get.”

In the study, researchers sequenced and assembled the genome of a humpback whale and compared it to other mammals. These included the blue whale, fin whale, bowhead whale and sperm whale.

They found that some parts of the whale genome contained genes that control the cell cycle, cell proliferation and DNA repair, which are essential for normal cell function. Many of these genes are mutated in human cancers. They also found that the whale genome also evolved many duplications in tumour suppressor genes.

Co-author Carlo Maley from Arizona State University said: “Nature is showing us that these changes to cancer genes are compatible with life. The next questions are, which of these changes is preventing cancer, and can we translate those discoveries into preventing cancer in humans?”

Tollis added: “This suggests that whales are unique among mammals in that in order to evolve their gigantic sizes, these important ‘housekeeping’ genes, that are evolutionarily conserved and normally prevent cancer, had to keep up in order to maintain the species’ fitness.

“We also found that despite these cancer-related parts of whale genomes evolving faster than other mammals, on average whales have accumulated far fewer DNA mutations in their genomes over time compared to other mammals, which suggests they have slower mutation rates.”

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.